Gilead Sciences, Inc. (FRA:GIS)
106.20
+2.18 (2.10%)
At close: Dec 19, 2025
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
€1,408,571
Profits / Employee
€392,736
Market Cap
131.60B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17,600 | -400 | -2.22% |
| Dec 31, 2023 | 18,000 | 1,000 | 5.88% |
| Dec 31, 2022 | 17,000 | 2,600 | 18.06% |
| Dec 31, 2021 | 14,400 | 800 | 5.88% |
| Dec 31, 2020 | 13,600 | 1,800 | 15.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Deutsche Post AG | 573,964 |
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
Gilead Sciences News
- 2 days ago - Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
- 2 days ago - Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay - WSJ
- 2 days ago - Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
- 2 days ago - Trump strikes deal with US drugmakers to cut Medicaid medicine costs - The Guardian
- 2 days ago - Gilead (GILD) Strikes Deal to Cut Drug Costs With U.S. Government - GuruFocus
- 2 days ago - Nine of the largest pharma companies ink deals with Trump to lower drug prices - CNBC
- 2 days ago - Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans - Business Wire
- 3 days ago - GILD's Lenacapavir Gains UK Approval for HIV-1 Prevention - GuruFocus